Skip to main content
OpenTrials
Completed

NCT Number: NCT02157454

Effect of a Website Offering Individual Patients' Experiences for Cancer Patients

Being diagnosed with cancer confronts patients with a severe disease and they need to learn to deal with a range of new challenges. In order to support patients in the coping process, the website www.krankheitserfahrungen.de provides patients free, reliable information about health issues by sharing peoples' real-life experiences. In our project, the investigators developed a new module on the website for patients with colorectal cancer.

The objective of our study is to evaluate if access to the new colorectal cancer module on the website www.krankheitserfahrungen.de increases patient's competence.

The investigators will conduct a two-arm randomized controlled trial. Patients affected by colorectal cancer will be randomized into an intervention and a control group: the intervention group will have access for two weeks to the website www.krankheitserfahrungen.de (colorectal cancer module) with cancer patients´ experiences. Patients in the control group will not receive any intervention but will have access to the website for two weeks after completing the study.

Patient competence is measured by the self-efficacy component of the German short form of the Cancer Behavior Inventory via an online questionnaire at baseline and after two weeks. A second follow-up assessment will be implemented six weeks after baseline.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Berlin School of Public Health

Berlin, State of Berlin, 13347, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with colorectal cancer within the last 3 years or with metastases or relapse after colorectal cancer
  • having access to internet

Exclusion criteria

  • Patients diagnosed with colorectal cancer more than 3 years ago and without metastases or relapse

Treatment and study plan

Website access

Other

Access to the colorectal cancer module of the website www.krankheitserfahrungen.de which provides free, reliable information about health issues by sharing people's real-life experiences

Primary outcomes

  1. Self-efficacy for coping with cancer (measured by the German short form of the Cancer Behavior Inventory)

    Time frame: after 2 weeks

Secondary outcomes

  1. Change in self-efficacy for coping with cancer (measured by the German short form of the Cancer Behavior Inventory)

    Time frame: At baseline and after 2 weeks

  2. Change in self-efficacy for coping with cancer (measured by the German short form of the Cancer Behavior Inventory)

    Time frame: At baseline and after 6 weeks

  3. Patient competence (assessed by a self-rating measure of patient competence in oncology in validation process)

    Time frame: After 2 weeks

  4. Patient competence (assessed by a self-rating measure of patient competence in oncology in validation process)

    Time frame: After 6 weeks

Sponsors and collaborators

Lead sponsor

Berlin School of Public Health

Other

Collaborators

  • Federal Ministry of Health, Germany

Registry information

Official study title

Randomized Controlled Trial to Evaluate the Effect of a Website Offering Individual Patient's Experiences on Patient Competence of Colorectal Cancer Patients

Acronym: DIPExRCT

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jun 6, 2014
Registry last updated
Nov 10, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.